AllianceBernstein
HLVX

AllianceBernstein’s HilleVax HLVX Stock Holding History

AllianceBernstein’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,850
Closed -$31.7K – 3271
2025
Q1 		$31.7K Hold
21,850
– – ﹤0.01% 3165
2024
Q4 		$45.2K Hold
21,850
– – ﹤0.01% 3191
2024
Q3 		$38.5K Hold
21,850
– – ﹤0.01% 3202
2024
Q2 		$316K Buy
21,850
+4,710
+27% +$64.7K ﹤0.01% 2893
2024
Q1 		$285K Buy
17,140
+2,580
+18% +$41.3K ﹤0.01% 2815
2023
Q4 		$234K Buy
14,560
+450
+3% +$5.98K ﹤0.01% 2936
2023
Q3 		$190K Buy
14,110
+1,960
+16% +$27.6K ﹤0.01% 2980
2023
Q2 		$209K Buy
+12,150
New +$188K ﹤0.01% 2966

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AllianceBernstein's HLVX Position: Q2 2025 in Review

AllianceBernstein sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 21,850 shares — an estimated $31.7K sold.

AllianceBernstein first reported a position in HLVX in Q2 2023 and held it in 8 quarters. The position peaked at $316K in Q2 2024. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

  • AllianceBernstein reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 21,850 HilleVax shares in Q2 2025, an estimated $31.7K.
  • AllianceBernstein first reported a position in HilleVax in Q2 2023 and held it in 8 quarters.
  • AllianceBernstein's HilleVax position peaked at $316K in Q2 2024.
  • 74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.